| HR | 95% CI | P -value |
---|---|---|---|
Baseline complications | Â | Â | Â |
 Renal insufficiency | 0.84 | 0.77–3.18 | 0.167 |
 Heart dysfunction | 0.89 | 0.81–4.13 | 0.241 |
 Cerebrovascular events | 0.96 | 0.79–2.14 | 0.383 |
 Co-exist with severe AR | 0.87 | 0.64–0.95 | 0.043 |
Imaging phenotype | Â | Â | Â |
 Cluster 1 imaging phenotype | 0.69 | 0.48–0.92 | 0.017 |
 Cluster 2 imaging phenotype | 1.27 | 0.77–4.21 | 0.441 |
 Cluster 3 imaging phenotype | 0.72 | 0.43–0.94 | 0.048 |
Baseline hypertensive severity | Â | Â | Â |
 Mild | 1.79 | 0.78–1.32 | 0.108 |
 Moderate | 1.03 | 0.82–2.11 | 0.094 |
 Severe | 0.87 | 0.63–3.18 | 0.069 |
Blood pressure control status | Â | Â | Â |
 Controlled | 2.13 | 1.32–3.78 | 0.047 |
 Improved | 1.97 | 0.89–2.31 | 0.136 |
 Failure | 0.74 | 0.68–1.32 | 0.087 |
Cluster 1+ controlled blood pressure | 1 (reference) | Â | Â |
 Cluster 1+ uncontrolled blood pressure | 0.64 | 0.52–0.89 | 0.031 |
 Cluster 2+ controlled blood pressure | 2.21 | 1.47–4.32 | 0.027 |
 Cluster 2+ uncontrolled blood pressure | 1.48 | 0.89–3.11 | 0.074 |
 Cluster 3+ controlled blood pressure | 1.13 | 0.91–2.33 | 0.069 |
 Cluster 3+ uncontrolled blood pressure | 0.83 | 0.76–0.92 | 0.048 |